196 results on '"Bayani J"'
Search Results
2. Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
3. Multimodal Biomarkers that Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance
4. Elected Officials' Governance on Educational Projects as Influenced by Their Leadership Aptitudes and Styles.
5. 138MO Prognostic performance of Breast Cancer Index (BCI) in postmenopausal women with early-stage HR+ breast cancer in the TEAM trial
6. Expression of TEL-JAK2 in Primary Human Hematopoietic Cells Drives Erythropoietin-Independent Erythropoiesis and Induces Myelofibrosis in vivo
7. 307P Identifying new biological subgroups of triple-negative breast cancer using next-generation integrative clustering pipeline
8. Lack of BCR/ABL reciprocal fusion in variant Philadelphia chromosome translocations: a use of double fusion signal FISH and spectral karyotyping
9. Advances in the detection of chromosomal aberrations using spectral karyotyping
10. Chromosomal instability in osteosarcoma and its association with centrosome abnormalities
11. Abstract P6-19-01: Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
12. Abstract P2-07-02: A newly derived combined clinical treatment score and immunohistochemical-4 prognostic tool
13. Abstract P5-04-24: Molecular stratification of ER+/HER2- breast cancer cell lines to predict sensitivity to targeted agents
14. Abstract P1-06-04: Simplified histological grading of breast carcinoma – potential for improved concordance and consistency in breast cancer grading?
15. Abstract P1-06-02: Comparative survival analysis of multiparametric tests in the TEAM pathology study: What to do when molecular tests disagree?
16. Abstract P2-10-01: Validation that a histone gene signature predicts anthracycline response in early breast cancer
17. Abstract P2-09-17: Evaluation of the oncomine comprehensive assay for the identification of actionable mutations for therapeutic stratification from the TEAM pathology cohort
18. Abstract PD7-12: Molecular subtyping of male breast cancer by the International male breast cancer program (IMBC): EORTC 10085/TBCRC 0-29/BIG 2-07/NABCG/BOOG 2009-04
19. Abstract PD4-11: Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers
20. Defining a signature of residual risk following endocrine treatment in the tamoxifen and exemestane adjuvant multinational (TEAM) trial
21. HER2 status as predictive marker for Al vs Tam benefit: A TRANS-AIOG meta-analysis of 12129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2
22. Defining a signature of residual risk following endocrine treatment in the tamoxifen and exemestane adjuvant multinational (TEAM) trial
23. Abstract P1-03-01: An international multicenter study to evaluate reproducibility of automated scoring methods for assessment of Ki67 in breast cancer
24. Abstract P1-05-27: Evaluation of the Oncomine focus and comprehensive assays for therapeutic stratification in early hormone receptor positive breast cancers
25. Does androgen receptor (AR) expression impact on residual risk? A TEAM pathology study
26. Spectral Karyotyping, Comparative Genomic Hybridization and Microarray Analysis of Primary Ovarian Tumours
27. Abstract P1-05-01: The epithelial to mesenchymal transition: Identifying a signature of recurrence in ductal carcinoma in situ
28. Abstract P2-08-29: Defining a signature of residual risk following endocrine treatment in the tamoxifen and exemestane adjuvant multinational (TEAM) trial
29. Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies
30. P065 Luminal A vs luminal B: impact of different St. Gallen Ki67 and PgR cut points in the TEAM study
31. SINGLE CELL DERIVED CLONAL ANALYSIS OF HUMAN GLIOBLASTOMA LINKS FUNCTIONAL AND GENOMIC HETEROGENEITY
32. Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients.
33. Integrated Cytogenetic and High-Resolution Array CGH Analysis of Genomic Alterations Associated with MYCN Amplification
34. Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH
35. Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotype evolution in prostate cancer
36. Precipitation analyses using SSM/I measurements for selected ERICA cyclones
37. Detection of novel variant TMPRSS2 /ERG fusion transcripts suggests independent genomic alterations may underlie origin of multi-centric prostate cancer
38. Use of whole genome amplification and comparative genomic hybridisation to detect chromosomal copy number alterations in cell line material and tumour tissue
39. High-resolution cDNA microarray CGH mapping of genomic imbalances in osteosarcoma using formalin-fixed paraffin-embedded tissue
40. Cytogenetic Findings in 36 Osteosarcoma Specimens and a Review of the Literature
41. Recurrent anomalies of 6q25 in chondromyxoid fibroma
42. Precipitation Analyses Using SSM/I Measurements for Selected ERICA Cyclones
43. Precipitation analyses using SSM/I measurements for selected ERICA cyclones
44. Molecular genetic analysis of MYCN and DDX1 co-amplification in pediatric solid tumours
45. Detection of gene amplification in pediatric solid tumors using a simplified comparative genomic hybridization technique
46. Acquisition of secondary structural chromosomal changes in pediatric ewing sarcoma is a probable prognostic factor for tumor response and clinical outcome.
47. CYTOGENETIC FINDINGS IN 36 OSTEOSARCOMA SPECIMENS AND A REVIEW OF THE LITERATURE.
48. Comparative genomic hybridization analysis identifies gains of 1p35p36 and chromosome 19 in osteosarcoma
49. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization
50. Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.